ERBB2 and renal pelvis/ureter urothelial carcinoma: ERBB2 amplification was also common in bladder cancer and UTUC (6.2%: 64 of 1032 bladder tumors and 4.4% of UTUC: 9 of 204 tumors, Fig. 5b).